[1] |
Jeon CY, Murray MB. Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies. PLoS Med, 2008, 5(7): e152. doi:10.1371/journal.pmed.0050152.
|
[2] |
Gautam S, Shrestha N, Mahato S, et al. Diabetes among tuberculosis patients and its impact on tuberculosis treatment in South Asia: a systematic review and meta-analysis. Sci Rep, 2021, 11(1): 2113. doi:10.1038/s41598-021-81057-2.
pmid: 33483542
|
[3] |
Li J, Liu CH, Wang FS. Thymosin alpha 1: biological activities, applications and genetic engineering production. Peptides, 2010, 31(11): 2151-2158. doi:10.1016/j.peptides.2010.07.026.
pmid: 20699109
|
[4] |
中华人民共和国国家卫生和计划生育委员会. WS 288—2017 肺结核诊断. 2017-11-09.
|
[5] |
American Diabetes Association. Standards of Care in Diabetes-2023. Diabetes Care, 2022, 46(Suppl1): S1-S291.
doi: 10.2337/dc23-Sint
URL
|
[6] |
董璇. 胸腺肽α1对糖尿病合并肺结核患者临床疗效的影响. 中国老年学杂志, 2015, 35(15): 4258-4260. doi:10.3969/j.issn.1005-9202.2015.15.066.
|
[7] |
张亚平. 胸腺肽α1联合抗结核方案治疗肺结核合并糖尿病临床效果及对外周血T淋巴细胞亚群的影响. 口岸卫生控制, 2019, 24(4): 38-41. doi:10.3969/j.issn.1008-5777.2019.04.010.
|
[8] |
辛志玲. 胰岛素、利福喷丁综合疗法联合胸腺肽α1对肺结核合并糖尿病效果探讨. 糖尿病新世界, 2021, 24(6): 99-101. doi:10.16658/j.cnki.1672-4062.2021.06.099.
|
[9] |
曹思哲, 郭玉琪. 胰岛素、利福平联合胸腺肽α1治疗肺结核合并糖尿病疗效及对患者CD3+、CD4+、CD8+的影响研究. 陕西医学杂志, 2018, 47(9): 1178-1180, 1184. doi:10.3969/j.issn.1000-7377.2018.09.024.
|
[10] |
朱洪坤. 26例肺结核合并糖尿病的临床疗效分析. 糖尿病新世界, 2016, 19(23): 134-135. doi:10.16658/j.cnki.1672-4062.2016.23.134.
|
[11] |
方祎, 黎秋芬, 刘亚南, 等. 126例初治肺结核合并糖尿病患者的临床治疗效果及对肾功能影响. 糖尿病新世界, 2017, 20(16): 11-12. doi:10.16658/j.cnki.1672-4062.2017.16.011.
|
[12] |
李小月, 张艳丽, 陈厦, 等. 免疫调节剂对肺结核合并2型糖尿病患者临床效果的影响. 临床误诊误治, 2020, 33(3): 31-36. doi:10.3969/j.issn.1002-3429.2020.03.009.
|
[13] |
张志诚. 胸腺肽α1治疗肺结核伴糖尿病的效果评价. 中外医疗, 2021, 40(1): 118-120. doi:10.16662/j.cnki.1674-0742.2021.01.118.
|
[14] |
Wu L, Luo PP, Tian YH, et al. Clinical efficacy of thymosin alpha 1 combined with multi-modality chemotherapy and its effects on immune function of patients with pulmonary tuberculosis complicated with diabetes. Pak J Med Sci, 2022, 38(1): 179-184. doi:10.12669/pjms.38.1.4419.
pmid: 35035422
|
[15] |
姚慧娟, 姚昆, 林厚雄, 等. 胸腺肽α1辅助治疗对2型糖尿病合并肺结核患者痰菌转阴及免疫应答的影响. 临床和实验医学杂志, 2020, 19(24): 2637-2640. doi:10.3969/j.issn.1671-4695.2020.24.016.
|
[16] |
马琴琴, 白大鹏, 孔伟利, 等. 胸腺肽α1辅助治疗肺结核合并糖尿病的病例对照研究. 临床荟萃, 2012, 27(1): 19-22.
|
[17] |
刘纯钢, 袁艳梅. 胸腺肽α1联合抗结核药物治疗肺结核合并糖尿病患者的疗效观察. 临床肺科杂志, 2014, 19(3): 560-561. doi:10.3969/j.issn.1009-6663.2014.03.069.
|
[18] |
曹瑛, 马天丽, 李俊, 等. 胸腺肽α1辅助治疗复治肺结核合并糖尿病对痰结核菌阴转率、T淋巴细胞亚群、PCT、sTREM-1、TFN-γ的影响. 河南预防医学杂志, 2021, 32(6): 478-482. doi:10.13515/j.cnki.hnjpm.1006-8414.2021.06.021.
|
[19] |
Li Y, Li D, Zhang J, et al. Association between Toll-like receptor 4 and occurrence of type 2 diabetes mellitus susceptible to pulmonary tuberculosis in Northeast China. Stem Cells Int, 2016, 2016: 8160318. doi:10.1155/2016/8160318.
|
[20] |
Riza AL, Pearson F, Ugarte-Gil C, et al. Clinical management of concurrent diabetes and tuberculosis and the implications for patient services. Lancet Diabetes Endocrinol, 2014, 2(9):740-753. doi:10.1016/S2213-8587(14)70110-X.
|
[21] |
Worku S, Hoft DF. Differential effects of control and antigen-specific T cells on intracellular mycobacterial growth. Infect Immun, 2003, 71(4): 1763-1773. doi:10.1128/IAI.71.4.1763-1773.2003.
pmid: 12654790
|
[22] |
李沛军. 胸腺肽α1与短程化疗联合治疗55例肺结核伴糖尿病者的疗效观察. 转化医学电子杂志, 2016, 3(1): 32-33.
|
[23] |
Sulaiman SAS, Khan AH, Ahmad N, et al. Impact of diabetes mellitus on treatment outcomes of tuberculosis patients in tertiary care setup. Am J Med Sci, 2013, 345(4): 321-325. doi:10.1097/MAJ.0b013e318288f8f3.
pmid: 23531965
|
[24] |
Cheekatla SS, Tripathi D, Venkatasubramanian S, et al. NK-CD11c+ cell crosstalk in diabetes enhances IL-6-mediated inflammation during Mycobacterium tuberculosis infection. PLoS Pathog, 2016, 12(10): e1005972. doi:10.1371/journal.ppat.1005972.
|
[25] |
梁旭峰, 梁虹, 汪关宝, 等. 胸腺肽-α1对肠结核患者免疫功能及临床疗效的影响. 中国临床药理学杂志, 2010, 26(3): 179-182. doi:10.3969/j.issn.1001-6821.2010.03.005.
|
[26] |
刁丽丽. 肺结核合并糖尿病患者的临床特点及抗结核治疗的疗效观察. 内科急危重症杂志, 2016, 22(4): 285-286, 293. doi:10.11768/nkjwzzzz20160413.
|
[27] |
刘建春, 杜敬华, 王晓军, 等. 胸腺肽在糖尿病合并肺结核患者中的应用. 临床肺科杂志, 2014, 19(10): 1838-1841. doi:10.3969/j.issn.1009-6663.2014.010.032.
|